Liu et al. found that T-cell proliferation was suppressed in metastatic breast cancer compared with primary breast cancer, and CD4+ T cells were more likely to differentiate into exhausted cells in metastatic breast cancer. This evidence concerns the gene CD4 and breast cancer.